ホーム > 市場調査レポート > 医薬品

バイオ医薬品

市場調査レポート

商品コード

1123496

世界の制限酵素市場：考察と予測 (2028年まで)

Global Restriction Endonucleases Market Insights and Forecast to 2028

出版日: 2022年09月08日 | 発行: QYResearch

| ページ情報: 英文 116 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　詳細はお問い合わせください。

価格

PDF (Single User License)

USD 4,900 771,064円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Multi User License)

USD 7,350 1,156,596円

レポートPDFを5名までご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise User License)

USD 9,800 1,542,128円

レポートPDFを企業内すべての方にご使用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=157.36円

ご注意事項 :

本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

当レポートは、制限酵素 (Restriction Endonucleases) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

制限酵素の製品概要
市場：タイプ別
- 世界の制限酵素の市場規模成長率：タイプ別, 2017 VS 2021 VS 2028
- Type I
- Type II
- Type III
- Type IV
- Others
市場：アプリケーション別
- 世界の制限酵素の市場規模成長率：アプリケーション別, 2017 VS 2021 VS 2028
- Academic & Research Institutes
- Hospitals & Diagnostic Centers
- Biopharmaceutical
- Others
調査目的
対象期間

第2章レポート概要

世界の制限酵素の販売推定および予測 2017-2028
世界の制限酵素の収益推定および予測 2017-2028
世界の制限酵素の収益：地域別: 2017 VS 2021 VS 2028
世界の制限酵素の販売：地域別
- 世界の制限酵素の販売：地域別 (2017-2022)
- 世界の販売制限酵素：地域別 (2023-2028)
世界の制限酵素の収益：地域別
- 世界の制限酵素の収益：地域別 (2017-2022)
- 世界の制限酵素の収益：地域別 (2023-2028)
北米
欧州
アジア太平洋地域
ラテンアメリカ
中東・アフリカ

第3章競合：メーカー別

世界の制限酵素の販売：メーカー別
- 世界の制限酵素の上位メーカー：販売別 (2017-2022)
- 世界の制限酵素の販売市場シェア：メーカー別 (2017-2022)
- 世界の上位10・上位5メーカー：制限酵素2021
世界の制限酵素の収益：メーカー別
- 世界の制限酵素の収益：メーカー別 (2017-2022)
- 世界の制限酵素の収益市場シェア：メーカー別 (2017-2022)
- 世界の上位10・上位5企業：制限酵素の収益 2021
世界の制限酵素の販売価格：メーカー別 (2017-2022)
競合情勢の分析
- メーカーの市場集中度 (CR5 and HHI)
- 世界の制限酵素の市場シェア：企業タイプ別 (Tier 1, Tier 2, and Tier 3)
- 世界の制限酵素のメーカーの地理的分布
M&A, 拡張計画

第4章市場規模：タイプ別

世界の制限酵素の販売：タイプ別
- 世界の制限酵素の販売実績：タイプ別 (2017-2022)
- 世界の制限酵素の販売予測：タイプ別 (2023-2028)
- 世界の制限酵素の販売市場シェア：タイプ別 (2017-2028)
世界の制限酵素の収益：タイプ別
- 世界の制限酵素の収益実績：タイプ別 (2017-2022)
- 世界の制限酵素の収益予測：タイプ別 (2023-2028)
- 世界の制限酵素の収益市場シェア：タイプ別 (2017-2028)
世界の制限酵素の価格：タイプ別
- 世界の制限酵素の価格：タイプ別 (2017-2022)
- 世界の制限酵素の価格予測：タイプ別 (2023-2028)

第5章市場規模：アプリケーション別

世界の制限酵素の販売：アプリケーション別
- 世界の制限酵素の販売実績：アプリケーション別 (2017-2022)
- 世界の制限酵素の販売予測：アプリケーション別 (2023-2028)
- 世界の制限酵素の販売市場シェア：アプリケーション別 (2017-2028)
世界の制限酵素の収益：アプリケーション別
- 世界の制限酵素の収益実績：アプリケーション別 (2017-2022)
- 世界の制限酵素の収益予測：アプリケーション別 (2023-2028)
- 世界の制限酵素の収益市場シェア：アプリケーション別 (2017-2028)
世界の制限酵素の価格：アプリケーション別
- 世界の制限酵素の価格：アプリケーション別 (2017-2022)
- 世界の制限酵素の価格予測：アプリケーション別 (2023-2028)

第6章北米

北米の制限酵素市場規模：タイプ別
- 北米の制限酵素の販売：タイプ別 (2017-2028)
- 北米の制限酵素の収益：タイプ別 (2017-2028)
北米の制限酵素市場規模：アプリケーション別
- 北米の制限酵素の販売：アプリケーション別 (2017-2028)
- 北米の制限酵素の収益：アプリケーション別 (2017-2028)
北米の制限酵素市場規模：国別
- 北米の制限酵素の販売：国別 (2017-2028)
- 北米の制限酵素の収益：国別 (2017-2028)
- 米国
- カナダ

第7章欧州

欧州の制限酵素市場規模：タイプ別
- 欧州の制限酵素の販売：タイプ別 (2017-2028)
- 欧州の制限酵素の収益：タイプ別 (2017-2028)
欧州の制限酵素市場規模：アプリケーション別
- 欧州の制限酵素の販売：アプリケーション別 (2017-2028)
- 欧州の制限酵素の収益：アプリケーション別 (2017-2028)
欧州の制限酵素市場規模：国別
- 欧州の制限酵素の販売：国別 (2017-2028)
- 欧州の制限酵素の収益：国別 (2017-2028)
- ドイツ
- フランス
- 英国
- イタリア
- ロシア

第8章アジア太平洋

アジア太平洋の制限酵素市場規模：タイプ別
- アジア太平洋の制限酵素の販売：タイプ別 (2017-2028)
- アジア太平洋の制限酵素の収益：タイプ別 (2017-2028)
アジア太平洋の制限酵素市場規模：アプリケーション別
- アジア太平洋の制限酵素の販売：アプリケーション別 (2017-2028)
- アジア太平洋の制限酵素の収益：アプリケーション別 (2017-2028)
アジア太平洋の制限酵素市場規模：地域別
- アジア太平洋の制限酵素の販売：地域別 (2017-2028)
- アジア太平洋の制限酵素の収益：地域別 (2017-2028)
- 中国
- 日本
- 韓国
- インド
- オーストラリア
- 台湾
- インドネシア
- タイ
- マレーシア
- フィリピン

第9章ラテンアメリカ

ラテンアメリカの制限酵素市場規模：タイプ別
- ラテンアメリカの制限酵素の販売：タイプ別 (2017-2028)
- ラテンアメリカの制限酵素の収益：タイプ別 (2017-2028)
ラテンアメリカの制限酵素市場規模：アプリケーション別
- ラテンアメリカの制限酵素の販売：アプリケーション別 (2017-2028)
- ラテンアメリカの制限酵素の収益：アプリケーション別 (2017-2028)
ラテンアメリカの制限酵素市場規模：国別
- ラテンアメリカの制限酵素の販売：国別 (2017-2028)
- ラテンアメリカの制限酵素の収益：国別 (2017-2028)
- メキシコ
- ブラジル
- アルゼンチン

第10章中東・アフリカ

中東・アフリカの制限酵素市場規模：タイプ別
- 中東・アフリカの制限酵素の販売：タイプ別 (2017-2028)
- 中東・アフリカの制限酵素の収益：タイプ別 (2017-2028)
中東・アフリカの制限酵素市場規模：アプリケーション別
- 中東・アフリカの制限酵素の販売：アプリケーション別 (2017-2028)
- 中東・アフリカの制限酵素の収益：アプリケーション別 (2017-2028)
中東・アフリカの制限酵素市場規模：国別
- 中東・アフリカの制限酵素の販売：国別 (2017-2028)
- 中東・アフリカの制限酵素の収益：国別 (2017-2028)
- トルコ
- サウジアラビア

第11章企業プロファイル

New England Biolabs
Thermo Fisher Scientific
Takara Bio
Illumina
Agilent
Roche
GE Healthcare
Promega
Qiagen
Jena Biosciences

第12章業界チェーンと販売チャネルの分析

制限酵素業界チェーン分析
制限酵素主要原材料分析
- 主要原材料分析
- 原材料の主要サプライヤー
制限酵素生産形態とプロセス
制限酵素販売およびマーケティング
- 制限酵素販売チャネル
- 制限酵素卸業者
制限酵素顧客

第13章市場の促進要因, 機会, 課題とリスク要因の分析

制限酵素業界動向
制限酵素市場の促進要因
制限酵素市場の課題
制限酵素市場の抑制要因

第14章世界の制限酵素の主な市場調査結果

第15章付録

図表

Table 1. Global Restriction Endonucleases Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Type I
Table 3. Major Manufacturers of Type II
Table 4. Major Manufacturers of Type III
Table 5. Major Manufacturers of Type IV
Table 6. Major Manufacturers of Others
Table 7. Global Restriction Endonucleases Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Restriction Endonucleases Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 9. Global Restriction Endonucleases Sales by Region (2017-2022) & (K Units)
Table 10. Global Restriction Endonucleases Sales Market Share by Region (2017-2022)
Table 11. Global Restriction Endonucleases Sales by Region (2023-2028) & (K Units)
Table 12. Global Restriction Endonucleases Sales Market Share by Region (2023-2028)
Table 13. Global Restriction Endonucleases Revenue by Region (2017-2022) & (US$ Million)
Table 14. Global Restriction Endonucleases Revenue Market Share by Region (2017-2022)
Table 15. Global Restriction Endonucleases Revenue by Region (2023-2028) & (US$ Million)
Table 16. Global Restriction Endonucleases Revenue Market Share by Region (2023-2028)
Table 17. Global Restriction Endonucleases Sales by Manufacturers (2017-2022) & (K Units)
Table 18. Global Restriction Endonucleases Sales Share by Manufacturers (2017-2022)
Table 19. Global Restriction Endonucleases Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 20. Global Restriction Endonucleases Revenue Share by Manufacturers (2017-2022)
Table 21. Restriction Endonucleases Price by Manufacturers (2017-2022) &(USD/Unit)
Table 22. Global Restriction Endonucleases Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Restriction Endonucleases by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Restriction Endonucleases as of 2021)
Table 24. Restriction Endonucleases Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Restriction Endonucleases Product Offered
Table 26. Date of Manufacturers Enter into Restriction Endonucleases Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Restriction Endonucleases Sales by Type (2017-2022) & (K Units)
Table 29. Global Restriction Endonucleases Sales by Type (2023-2028) & (K Units)
Table 30. Global Restriction Endonucleases Sales Share by Type (2017-2022)
Table 31. Global Restriction Endonucleases Sales Share by Type (2023-2028)
Table 32. Global Restriction Endonucleases Revenue by Type (2017-2022) & (US$ Million)
Table 33. Global Restriction Endonucleases Revenue by Type (2023-2028) & (US$ Million)
Table 34. Global Restriction Endonucleases Revenue Share by Type (2017-2022)
Table 35. Global Restriction Endonucleases Revenue Share by Type (2023-2028)
Table 36. Restriction Endonucleases Price by Type (2017-2022) & (USD/Unit)
Table 37. Global Restriction Endonucleases Price Forecast by Type (2023-2028) & (USD/Unit)
Table 38. Global Restriction Endonucleases Sales by Application (2017-2022) & (K Units)
Table 39. Global Restriction Endonucleases Sales by Application (2023-2028) & (K Units)
Table 40. Global Restriction Endonucleases Sales Share by Application (2017-2022)
Table 41. Global Restriction Endonucleases Sales Share by Application (2023-2028)
Table 42. Global Restriction Endonucleases Revenue by Application (2017-2022) & (US$ Million)
Table 43. Global Restriction Endonucleases Revenue by Application (2023-2028) & (US$ Million)
Table 44. Global Restriction Endonucleases Revenue Share by Application (2017-2022)
Table 45. Global Restriction Endonucleases Revenue Share by Application (2023-2028)
Table 46. Restriction Endonucleases Price by Application (2017-2022) & (USD/Unit)
Table 47. Global Restriction Endonucleases Price Forecast by Application (2023-2028) & (USD/Unit)
Table 48. North America Restriction Endonucleases Sales by Type (2017-2022) & (K Units)
Table 49. North America Restriction Endonucleases Sales by Type (2023-2028) & (K Units)
Table 50. North America Restriction Endonucleases Revenue by Type (2017-2022) & (US$ Million)
Table 51. North America Restriction Endonucleases Revenue by Type (2023-2028) & (US$ Million)
Table 52. North America Restriction Endonucleases Sales by Application (2017-2022) & (K Units)
Table 53. North America Restriction Endonucleases Sales by Application (2023-2028) & (K Units)
Table 54. North America Restriction Endonucleases Revenue by Application (2017-2022) & (US$ Million)
Table 55. North America Restriction Endonucleases Revenue by Application (2023-2028) & (US$ Million)
Table 56. North America Restriction Endonucleases Sales by Country (2017-2022) & (K Units)
Table 57. North America Restriction Endonucleases Sales by Country (2023-2028) & (K Units)
Table 58. North America Restriction Endonucleases Revenue by Country (2017-2022) & (US$ Million)
Table 59. North America Restriction Endonucleases Revenue by Country (2023-2028) & (US$ Million)
Table 60. Europe Restriction Endonucleases Sales by Type (2017-2022) & (K Units)
Table 61. Europe Restriction Endonucleases Sales by Type (2023-2028) & (K Units)
Table 62. Europe Restriction Endonucleases Revenue by Type (2017-2022) & (US$ Million)
Table 63. Europe Restriction Endonucleases Revenue by Type (2023-2028) & (US$ Million)
Table 64. Europe Restriction Endonucleases Sales by Application (2017-2022) & (K Units)
Table 65. Europe Restriction Endonucleases Sales by Application (2023-2028) & (K Units)
Table 66. Europe Restriction Endonucleases Revenue by Application (2017-2022) & (US$ Million)
Table 67. Europe Restriction Endonucleases Revenue by Application (2023-2028) & (US$ Million)
Table 68. Europe Restriction Endonucleases Sales by Country (2017-2022) & (K Units)
Table 69. Europe Restriction Endonucleases Sales by Country (2023-2028) & (K Units)
Table 70. Europe Restriction Endonucleases Revenue by Country (2017-2022) & (US$ Million)
Table 71. Europe Restriction Endonucleases Revenue by Country (2023-2028) & (US$ Million)
Table 72. Asia Pacific Restriction Endonucleases Sales by Type (2017-2022) & (K Units)
Table 73. Asia Pacific Restriction Endonucleases Sales by Type (2023-2028) & (K Units)
Table 74. Asia Pacific Restriction Endonucleases Revenue by Type (2017-2022) & (US$ Million)
Table 75. Asia Pacific Restriction Endonucleases Revenue by Type (2023-2028) & (US$ Million)
Table 76. Asia Pacific Restriction Endonucleases Sales by Application (2017-2022) & (K Units)
Table 77. Asia Pacific Restriction Endonucleases Sales by Application (2023-2028) & (K Units)
Table 78. Asia Pacific Restriction Endonucleases Revenue by Application (2017-2022) & (US$ Million)
Table 79. Asia Pacific Restriction Endonucleases Revenue by Application (2023-2028) & (US$ Million)
Table 80. Asia Pacific Restriction Endonucleases Sales by Region (2017-2022) & (K Units)
Table 81. Asia Pacific Restriction Endonucleases Sales by Region (2023-2028) & (K Units)
Table 82. Asia Pacific Restriction Endonucleases Revenue by Region (2017-2022) & (US$ Million)
Table 83. Asia Pacific Restriction Endonucleases Revenue by Region (2023-2028) & (US$ Million)
Table 84. Latin America Restriction Endonucleases Sales by Type (2017-2022) & (K Units)
Table 85. Latin America Restriction Endonucleases Sales by Type (2023-2028) & (K Units)
Table 86. Latin America Restriction Endonucleases Revenue by Type (2017-2022) & (US$ Million)
Table 87. Latin America Restriction Endonucleases Revenue by Type (2023-2028) & (US$ Million)
Table 88. Latin America Restriction Endonucleases Sales by Application (2017-2022) & (K Units)
Table 89. Latin America Restriction Endonucleases Sales by Application (2023-2028) & (K Units)
Table 90. Latin America Restriction Endonucleases Revenue by Application (2017-2022) & (US$ Million)
Table 91. Latin America Restriction Endonucleases Revenue by Application (2023-2028) & (US$ Million)
Table 92. Latin America Restriction Endonucleases Sales by Country (2017-2022) & (K Units)
Table 93. Latin America Restriction Endonucleases Sales by Country (2023-2028) & (K Units)
Table 94. Latin America Restriction Endonucleases Revenue by Country (2017-2022) & (US$ Million)
Table 95. Latin America Restriction Endonucleases Revenue by Country (2023-2028) & (US$ Million)
Table 96. Middle East and Africa Restriction Endonucleases Sales by Type (2017-2022) & (K Units)
Table 97. Middle East and Africa Restriction Endonucleases Sales by Type (2023-2028) & (K Units)
Table 98. Middle East and Africa Restriction Endonucleases Revenue by Type (2017-2022) & (US$ Million)
Table 99. Middle East and Africa Restriction Endonucleases Revenue by Type (2023-2028) & (US$ Million)
Table 100. Middle East and Africa Restriction Endonucleases Sales by Application (2017-2022) & (K Units)
Table 101. Middle East and Africa Restriction Endonucleases Sales by Application (2023-2028) & (K Units)
Table 102. Middle East and Africa Restriction Endonucleases Revenue by Application (2017-2022) & (US$ Million)
Table 103. Middle East and Africa Restriction Endonucleases Revenue by Application (2023-2028) & (US$ Million)
Table 104. Middle East and Africa Restriction Endonucleases Sales by Country (2017-2022) & (K Units)
Table 105. Middle East and Africa Restriction Endonucleases Sales by Country (2023-2028) & (K Units)
Table 106. Middle East and Africa Restriction Endonucleases Revenue by Country (2017-2022) & (US$ Million)
Table 107. Middle East and Africa Restriction Endonucleases Revenue by Country (2023-2028) & (US$ Million)
Table 108. New England Biolabs Corporation Information
Table 109. New England Biolabs Description and Major Businesses
Table 110. New England Biolabs Restriction Endonucleases Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 111. New England Biolabs Restriction Endonucleases Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. New England Biolabs Recent Developments
Table 113. Thermo Fisher Scientific Corporation Information
Table 114. Thermo Fisher Scientific Description and Major Businesses
Table 115. Thermo Fisher Scientific Restriction Endonucleases Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 116. Thermo Fisher Scientific Restriction Endonucleases Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. Thermo Fisher Scientific Recent Developments
Table 118. Takara Bio Corporation Information
Table 119. Takara Bio Description and Major Businesses
Table 120. Takara Bio Restriction Endonucleases Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 121. Takara Bio Restriction Endonucleases Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Takara Bio Recent Developments
Table 123. Illumina Corporation Information
Table 124. Illumina Description and Major Businesses
Table 125. Illumina Restriction Endonucleases Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 126. Illumina Restriction Endonucleases Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. Illumina Recent Developments
Table 128. Agilent Corporation Information
Table 129. Agilent Description and Major Businesses
Table 130. Agilent Restriction Endonucleases Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 131. Agilent Restriction Endonucleases Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. Agilent Recent Developments
Table 133. Roche Corporation Information
Table 134. Roche Description and Major Businesses
Table 135. Roche Restriction Endonucleases Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 136. Roche Restriction Endonucleases Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. Roche Recent Developments
Table 138. GE Healthcare Corporation Information
Table 139. GE Healthcare Description and Major Businesses
Table 140. GE Healthcare Restriction Endonucleases Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 141. GE Healthcare Restriction Endonucleases Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. GE Healthcare Recent Developments
Table 143. Promega Corporation Information
Table 144. Promega Description and Major Businesses
Table 145. Promega Restriction Endonucleases Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 146. Promega Restriction Endonucleases Product Model Numbers, Pictures, Descriptions and Specifications
Table 147. Promega Recent Developments
Table 148. Qiagen Corporation Information
Table 149. Qiagen Description and Major Businesses
Table 150. Qiagen Restriction Endonucleases Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 151. Qiagen Restriction Endonucleases Product Model Numbers, Pictures, Descriptions and Specifications
Table 152. Qiagen Recent Developments
Table 153. Jena Biosciences Corporation Information
Table 154. Jena Biosciences Description and Major Businesses
Table 155. Jena Biosciences Restriction Endonucleases Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 156. Jena Biosciences Restriction Endonucleases Product Model Numbers, Pictures, Descriptions and Specifications
Table 157. Jena Biosciences Recent Developments
Table 158. Key Raw Materials Lists
Table 159. Raw Materials Key Suppliers Lists
Table 160. Restriction Endonucleases Distributors List
Table 161. Restriction Endonucleases Customers List
Table 162. Restriction Endonucleases Market Trends
Table 163. Restriction Endonucleases Market Drivers
Table 164. Restriction Endonucleases Market Challenges
Table 165. Restriction Endonucleases Market Restraints
Table 166. Research Programs/Design for This Report
Table 167. Key Data Information from Secondary Sources
Table 168. Key Data Information from Primary Sources

List of Figures

Figure 1. Restriction Endonucleases Product Picture
Figure 3. Global Restriction Endonucleases Market Share by Type in 2021 & 2028
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Type III Product Picture
Figure 6. Type IV Product Picture
Figure 7. Others Product Picture
Figure 8. Global Restriction Endonucleases Market Share by Application in 2021 & 2028
Figure 9. Academic & Research Institutes
Figure 10. Hospitals & Diagnostic Centers
Figure 11. Biopharmaceutical
Figure 12. Others
Figure 13. Restriction Endonucleases Report Years Considered
Figure 14. Global Restriction Endonucleases Sales 2017-2028 (K Units)
Figure 15. Global Restriction Endonucleases Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 16. Global Restriction Endonucleases Revenue 2017-2028 (US$ Million)
Figure 17. Global Restriction Endonucleases Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 18. Global Restriction Endonucleases Sales Market Share by Region (2017-2022)
Figure 19. Global Restriction Endonucleases Sales Market Share by Region (2023-2028)
Figure 20. North America Restriction Endonucleases Sales YoY (2017-2028) & (K Units)
Figure 21. North America Restriction Endonucleases Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Europe Restriction Endonucleases Sales YoY (2017-2028) & (K Units)
Figure 23. Europe Restriction Endonucleases Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Asia-Pacific Restriction Endonucleases Sales YoY (2017-2028) & (K Units)
Figure 25. Asia-Pacific Restriction Endonucleases Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Latin America Restriction Endonucleases Sales YoY (2017-2028) & (K Units)
Figure 27. Latin America Restriction Endonucleases Revenue YoY (2017-2028) & (US$ Million)
Figure 28. Middle East & Africa Restriction Endonucleases Sales YoY (2017-2028) & (K Units)
Figure 29. Middle East & Africa Restriction Endonucleases Revenue YoY (2017-2028) & (US$ Million)
Figure 30. The Restriction Endonucleases Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 31. The Top 5 and 10 Largest Manufacturers of Restriction Endonucleases in the World: Market Share by Restriction Endonucleases Revenue in 2021
Figure 32. Global Restriction Endonucleases Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 33. Global Restriction Endonucleases Sales Market Share by Type (2017-2028)
Figure 34. Global Restriction Endonucleases Revenue Market Share by Type (2017-2028)
Figure 35. Global Restriction Endonucleases Sales Market Share by Application (2017-2028)
Figure 36. Global Restriction Endonucleases Revenue Market Share by Application (2017-2028)
Figure 37. North America Restriction Endonucleases Sales Market Share by Type (2017-2028)
Figure 38. North America Restriction Endonucleases Revenue Market Share by Type (2017-2028)
Figure 39. North America Restriction Endonucleases Sales Market Share by Application (2017-2028)
Figure 40. North America Restriction Endonucleases Revenue Market Share by Application (2017-2028)
Figure 41. North America Restriction Endonucleases Sales Share by Country (2017-2028)
Figure 42. North America Restriction Endonucleases Revenue Share by Country (2017-2028)
Figure 43. U.S. Restriction Endonucleases Revenue (2017-2028) & (US$ Million)
Figure 44. Canada Restriction Endonucleases Revenue (2017-2028) & (US$ Million)
Figure 45. Europe Restriction Endonucleases Sales Market Share by Type (2017-2028)
Figure 46. Europe Restriction Endonucleases Revenue Market Share by Type (2017-2028)
Figure 47. Europe Restriction Endonucleases Sales Market Share by Application (2017-2028)
Figure 48. Europe Restriction Endonucleases Revenue Market Share by Application (2017-2028)
Figure 49. Europe Restriction Endonucleases Sales Share by Country (2017-2028)
Figure 50. Europe Restriction Endonucleases Revenue Share by Country (2017-2028)
Figure 51. Germany Restriction Endonucleases Revenue (2017-2028) & (US$ Million)
Figure 52. France Restriction Endonucleases Revenue (2017-2028) & (US$ Million)
Figure 53. U.K. Restriction Endonucleases Revenue (2017-2028) & (US$ Million)
Figure 54. Italy Restriction Endonucleases Revenue (2017-2028) & (US$ Million)
Figure 55. Russia Restriction Endonucleases Revenue (2017-2028) & (US$ Million)
Figure 56. Asia Pacific Restriction Endonucleases Sales Market Share by Type (2017-2028)
Figure 57. Asia Pacific Restriction Endonucleases Revenue Market Share by Type (2017-2028)
Figure 58. Asia Pacific Restriction Endonucleases Sales Market Share by Application (2017-2028)
Figure 59. Asia Pacific Restriction Endonucleases Revenue Market Share by Application (2017-2028)
Figure 60. Asia Pacific Restriction Endonucleases Sales Share by Region (2017-2028)
Figure 61. Asia Pacific Restriction Endonucleases Revenue Share by Region (2017-2028)
Figure 62. China Restriction Endonucleases Revenue (2017-2028) & (US$ Million)
Figure 63. Japan Restriction Endonucleases Revenue (2017-2028) & (US$ Million)
Figure 64. South Korea Restriction Endonucleases Revenue (2017-2028) & (US$ Million)
Figure 65. India Restriction Endonucleases Revenue (2017-2028) & (US$ Million)
Figure 66. Australia Restriction Endonucleases Revenue (2017-2028) & (US$ Million)
Figure 67. Taiwan Restriction Endonucleases Revenue (2017-2028) & (US$ Million)
Figure 68. Indonesia Restriction Endonucleases Revenue (2017-2028) & (US$ Million)
Figure 69. Thailand Restriction Endonucleases Revenue (2017-2028) & (US$ Million)
Figure 70. Malaysia Restriction Endonucleases Revenue (2017-2028) & (US$ Million)
Figure 71. Philippines Restriction Endonucleases Revenue (2017-2028) & (US$ Million)
Figure 72. Latin America Restriction Endonucleases Sales Market Share by Type (2017-2028)
Figure 73. Latin America Restriction Endonucleases Revenue Market Share by Type (2017-2028)
Figure 74. Latin America Restriction Endonucleases Sales Market Share by Application (2017-2028)
Figure 75. Latin America Restriction Endonucleases Revenue Market Share by Application (2017-2028)
Figure 76. Latin America Restriction Endonucleases Sales Share by Country (2017-2028)
Figure 77. Latin America Restriction Endonucleases Revenue Share by Country (2017-2028)
Figure 78. Mexico Restriction Endonucleases Revenue (2017-2028) & (US$ Million)
Figure 79. Brazil Restriction Endonucleases Revenue (2017-2028) & (US$ Million)
Figure 80. Argentina Restriction Endonucleases Revenue (2017-2028) & (US$ Million)
Figure 81. Middle East and Africa Restriction Endonucleases Sales Market Share by Type (2017-2028)
Figure 82. Middle East and Africa Restriction Endonucleases Revenue Market Share by Type (2017-2028)
Figure 83. Middle East and Africa Restriction Endonucleases Sales Market Share by Application (2017-2028)
Figure 84. Middle East and Africa Restriction Endonucleases Revenue Market Share by Application (2017-2028)
Figure 85. Middle East and Africa Restriction Endonucleases Sales Share by Country (2017-2028)
Figure 86. Middle East and Africa Restriction Endonucleases Revenue Share by Country (2017-2028)
Figure 87. Turkey Restriction Endonucleases Revenue (2017-2028) & (US$ Million)
Figure 88. Saudi Arabia Restriction Endonucleases Revenue (2017-2028) & (US$ Million)
Figure 89. U.A.E Restriction Endonucleases Revenue (2017-2028) & (US$ Million)
Figure 90. Restriction Endonucleases Value Chain
Figure 91. Restriction Endonucleases Production Process
Figure 92. Channels of Distribution
Figure 93. Distributors Profiles
Figure 94. Bottom-up and Top-down Approaches for This Report
Figure 95. Data Triangulation
Figure 96. Key Executives Interviewed

This research report focuses on the Restriction Endonucleases Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

1 Study Coverage

1.1 Restriction Endonucleases Product Introduction
1.2 Market by Type
- 1.2.1 Global Restriction Endonucleases Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
- 1.2.2 Type I
- 1.2.3 Type II
- 1.2.4 Type III
- 1.2.5 Type IV
- 1.2.6 Others
1.3 Market by Application
- 1.3.1 Global Restriction Endonucleases Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
- 1.3.2 Academic & Research Institutes
- 1.3.3 Hospitals & Diagnostic Centers
- 1.3.4 Biopharmaceutical
- 1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary

2.1 Global Restriction Endonucleases Sales Estimates and Forecasts 2017-2028
2.2 Global Restriction Endonucleases Revenue Estimates and Forecasts 2017-2028
2.3 Global Restriction Endonucleases Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Restriction Endonucleases Sales by Region
- 2.4.1 Global Restriction Endonucleases Sales by Region (2017-2022)
- 2.4.2 Global Sales Restriction Endonucleases by Region (2023-2028)
2.5 Global Restriction Endonucleases Revenue by Region
- 2.5.1 Global Restriction Endonucleases Revenue by Region (2017-2022)
- 2.5.2 Global Restriction Endonucleases Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa

3 Competition by Manufacturers

3.1 Global Restriction Endonucleases Sales by Manufacturers
- 3.1.1 Global Top Restriction Endonucleases Manufacturers by Sales (2017-2022)
- 3.1.2 Global Restriction Endonucleases Sales Market Share by Manufacturers (2017-2022)
- 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Restriction Endonucleases in 2021
3.2 Global Restriction Endonucleases Revenue by Manufacturers
- 3.2.1 Global Restriction Endonucleases Revenue by Manufacturers (2017-2022)
- 3.2.2 Global Restriction Endonucleases Revenue Market Share by Manufacturers (2017-2022)
- 3.2.3 Global Top 10 and Top 5 Companies by Restriction Endonucleases Revenue in 2021
3.3 Global Restriction Endonucleases Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
- 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
- 3.4.2 Global Restriction Endonucleases Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.4.3 Global Restriction Endonucleases Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Restriction Endonucleases Sales by Type
- 4.1.1 Global Restriction Endonucleases Historical Sales by Type (2017-2022)
- 4.1.2 Global Restriction Endonucleases Forecasted Sales by Type (2023-2028)
- 4.1.3 Global Restriction Endonucleases Sales Market Share by Type (2017-2028)
4.2 Global Restriction Endonucleases Revenue by Type
- 4.2.1 Global Restriction Endonucleases Historical Revenue by Type (2017-2022)
- 4.2.2 Global Restriction Endonucleases Forecasted Revenue by Type (2023-2028)
- 4.2.3 Global Restriction Endonucleases Revenue Market Share by Type (2017-2028)
4.3 Global Restriction Endonucleases Price by Type
- 4.3.1 Global Restriction Endonucleases Price by Type (2017-2022)
- 4.3.2 Global Restriction Endonucleases Price Forecast by Type (2023-2028)

5 Market Size by Application

5.1 Global Restriction Endonucleases Sales by Application
- 5.1.1 Global Restriction Endonucleases Historical Sales by Application (2017-2022)
- 5.1.2 Global Restriction Endonucleases Forecasted Sales by Application (2023-2028)
- 5.1.3 Global Restriction Endonucleases Sales Market Share by Application (2017-2028)
5.2 Global Restriction Endonucleases Revenue by Application
- 5.2.1 Global Restriction Endonucleases Historical Revenue by Application (2017-2022)
- 5.2.2 Global Restriction Endonucleases Forecasted Revenue by Application (2023-2028)
- 5.2.3 Global Restriction Endonucleases Revenue Market Share by Application (2017-2028)
5.3 Global Restriction Endonucleases Price by Application
- 5.3.1 Global Restriction Endonucleases Price by Application (2017-2022)
- 5.3.2 Global Restriction Endonucleases Price Forecast by Application (2023-2028)

6 North America

6.1 North America Restriction Endonucleases Market Size by Type
- 6.1.1 North America Restriction Endonucleases Sales by Type (2017-2028)
- 6.1.2 North America Restriction Endonucleases Revenue by Type (2017-2028)
6.2 North America Restriction Endonucleases Market Size by Application
- 6.2.1 North America Restriction Endonucleases Sales by Application (2017-2028)
- 6.2.2 North America Restriction Endonucleases Revenue by Application (2017-2028)
6.3 North America Restriction Endonucleases Market Size by Country
- 6.3.1 North America Restriction Endonucleases Sales by Country (2017-2028)
- 6.3.2 North America Restriction Endonucleases Revenue by Country (2017-2028)
- 6.3.3 U.S.
- 6.3.4 Canada

7 Europe

7.1 Europe Restriction Endonucleases Market Size by Type
- 7.1.1 Europe Restriction Endonucleases Sales by Type (2017-2028)
- 7.1.2 Europe Restriction Endonucleases Revenue by Type (2017-2028)
7.2 Europe Restriction Endonucleases Market Size by Application
- 7.2.1 Europe Restriction Endonucleases Sales by Application (2017-2028)
- 7.2.2 Europe Restriction Endonucleases Revenue by Application (2017-2028)
7.3 Europe Restriction Endonucleases Market Size by Country
- 7.3.1 Europe Restriction Endonucleases Sales by Country (2017-2028)
- 7.3.2 Europe Restriction Endonucleases Revenue by Country (2017-2028)
- 7.3.3 Germany
- 7.3.4 France
- 7.3.5 U.K.
- 7.3.6 Italy
- 7.3.7 Russia

8 Asia Pacific

8.1 Asia Pacific Restriction Endonucleases Market Size by Type
- 8.1.1 Asia Pacific Restriction Endonucleases Sales by Type (2017-2028)
- 8.1.2 Asia Pacific Restriction Endonucleases Revenue by Type (2017-2028)
8.2 Asia Pacific Restriction Endonucleases Market Size by Application
- 8.2.1 Asia Pacific Restriction Endonucleases Sales by Application (2017-2028)
- 8.2.2 Asia Pacific Restriction Endonucleases Revenue by Application (2017-2028)
8.3 Asia Pacific Restriction Endonucleases Market Size by Region
- 8.3.1 Asia Pacific Restriction Endonucleases Sales by Region (2017-2028)
- 8.3.2 Asia Pacific Restriction Endonucleases Revenue by Region (2017-2028)
- 8.3.3 China
- 8.3.4 Japan
- 8.3.5 South Korea
- 8.3.6 India
- 8.3.7 Australia
- 8.3.8 Taiwan
- 8.3.9 Indonesia
- 8.3.10 Thailand
- 8.3.11 Malaysia
- 8.3.12 Philippines

9 Latin America

9.1 Latin America Restriction Endonucleases Market Size by Type
- 9.1.1 Latin America Restriction Endonucleases Sales by Type (2017-2028)
- 9.1.2 Latin America Restriction Endonucleases Revenue by Type (2017-2028)
9.2 Latin America Restriction Endonucleases Market Size by Application
- 9.2.1 Latin America Restriction Endonucleases Sales by Application (2017-2028)
- 9.2.2 Latin America Restriction Endonucleases Revenue by Application (2017-2028)
9.3 Latin America Restriction Endonucleases Market Size by Country
- 9.3.1 Latin America Restriction Endonucleases Sales by Country (2017-2028)
- 9.3.2 Latin America Restriction Endonucleases Revenue by Country (2017-2028)
- 9.3.3 Mexico
- 9.3.4 Brazil
- 9.3.5 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Restriction Endonucleases Market Size by Type
- 10.1.1 Middle East and Africa Restriction Endonucleases Sales by Type (2017-2028)
- 10.1.2 Middle East and Africa Restriction Endonucleases Revenue by Type (2017-2028)
10.2 Middle East and Africa Restriction Endonucleases Market Size by Application
- 10.2.1 Middle East and Africa Restriction Endonucleases Sales by Application (2017-2028)
- 10.2.2 Middle East and Africa Restriction Endonucleases Revenue by Application (2017-2028)
10.3 Middle East and Africa Restriction Endonucleases Market Size by Country
- 10.3.1 Middle East and Africa Restriction Endonucleases Sales by Country (2017-2028)
- 10.3.2 Middle East and Africa Restriction Endonucleases Revenue by Country (2017-2028)
- 10.3.3 Turkey
- 10.3.4 Saudi Arabia

11 Company Profiles

11.1 New England Biolabs
- 11.1.1 New England Biolabs Corporation Information
- 11.1.2 New England Biolabs Overview
- 11.1.3 New England Biolabs Restriction Endonucleases Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.1.4 New England Biolabs Restriction Endonucleases Product Model Numbers, Pictures, Descriptions and Specifications
- 11.1.5 New England Biolabs Recent Developments
11.2 Thermo Fisher Scientific
- 11.2.1 Thermo Fisher Scientific Corporation Information
- 11.2.2 Thermo Fisher Scientific Overview
- 11.2.3 Thermo Fisher Scientific Restriction Endonucleases Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.2.4 Thermo Fisher Scientific Restriction Endonucleases Product Model Numbers, Pictures, Descriptions and Specifications
- 11.2.5 Thermo Fisher Scientific Recent Developments
11.3 Takara Bio
- 11.3.1 Takara Bio Corporation Information
- 11.3.2 Takara Bio Overview
- 11.3.3 Takara Bio Restriction Endonucleases Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.3.4 Takara Bio Restriction Endonucleases Product Model Numbers, Pictures, Descriptions and Specifications
- 11.3.5 Takara Bio Recent Developments
11.4 Illumina
- 11.4.1 Illumina Corporation Information
- 11.4.2 Illumina Overview
- 11.4.3 Illumina Restriction Endonucleases Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.4.4 Illumina Restriction Endonucleases Product Model Numbers, Pictures, Descriptions and Specifications
- 11.4.5 Illumina Recent Developments
11.5 Agilent
- 11.5.1 Agilent Corporation Information
- 11.5.2 Agilent Overview
- 11.5.3 Agilent Restriction Endonucleases Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.5.4 Agilent Restriction Endonucleases Product Model Numbers, Pictures, Descriptions and Specifications
- 11.5.5 Agilent Recent Developments
11.6 Roche
- 11.6.1 Roche Corporation Information
- 11.6.2 Roche Overview
- 11.6.3 Roche Restriction Endonucleases Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.6.4 Roche Restriction Endonucleases Product Model Numbers, Pictures, Descriptions and Specifications
- 11.6.5 Roche Recent Developments
11.7 GE Healthcare
- 11.7.1 GE Healthcare Corporation Information
- 11.7.2 GE Healthcare Overview
- 11.7.3 GE Healthcare Restriction Endonucleases Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.7.4 GE Healthcare Restriction Endonucleases Product Model Numbers, Pictures, Descriptions and Specifications
- 11.7.5 GE Healthcare Recent Developments
11.8 Promega
- 11.8.1 Promega Corporation Information
- 11.8.2 Promega Overview
- 11.8.3 Promega Restriction Endonucleases Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.8.4 Promega Restriction Endonucleases Product Model Numbers, Pictures, Descriptions and Specifications
- 11.8.5 Promega Recent Developments
11.9 Qiagen
- 11.9.1 Qiagen Corporation Information
- 11.9.2 Qiagen Overview
- 11.9.3 Qiagen Restriction Endonucleases Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.9.4 Qiagen Restriction Endonucleases Product Model Numbers, Pictures, Descriptions and Specifications
- 11.9.5 Qiagen Recent Developments
11.10 Jena Biosciences
- 11.10.1 Jena Biosciences Corporation Information
- 11.10.2 Jena Biosciences Overview
- 11.10.3 Jena Biosciences Restriction Endonucleases Sales, Price, Revenue and Gross Margin (2017-2022)
- 11.10.4 Jena Biosciences Restriction Endonucleases Product Model Numbers, Pictures, Descriptions and Specifications
- 11.10.5 Jena Biosciences Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Restriction Endonucleases Industry Chain Analysis
12.2 Restriction Endonucleases Key Raw Materials
- 12.2.1 Key Raw Materials
- 12.2.2 Raw Materials Key Suppliers
12.3 Restriction Endonucleases Production Mode & Process
12.4 Restriction Endonucleases Sales and Marketing
- 12.4.1 Restriction Endonucleases Sales Channels
- 12.4.2 Restriction Endonucleases Distributors
12.5 Restriction Endonucleases Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

13.1 Restriction Endonucleases Industry Trends
13.2 Restriction Endonucleases Market Drivers
13.3 Restriction Endonucleases Market Challenges
13.4 Restriction Endonucleases Market Restraints

14 Key Findings in The Global Restriction Endonucleases Study

15 Appendix

15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

ライセンス / 価格

PDF (Single User License)

USD 4,900 771,064円

PDF (Multi User License)

USD 7,350 1,156,596円

PDF (Enterprise User License)

USD 9,800 1,542,128円

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=157.36円

お電話でのお問い合わせ

044-952-0102

( 土日・祝日を除く )

制限エンドヌクレアーゼ

世界の制限酵素市場：考察と予測 (2028年まで)

Global Restriction Endonucleases Market Insights and Forecast to 2028

目次

第1章調査対象

第2章レポート概要

第3章競合：メーカー別

第4章市場規模：タイプ別

第5章市場規模：アプリケーション別

第6章北米

第7章欧州

第8章アジア太平洋

第9章ラテンアメリカ

第10章中東・アフリカ

第11章企業プロファイル

第12章業界チェーンと販売チャネルの分析

第13章市場の促進要因, 機会, 課題とリスク要因の分析

第14章世界の制限酵素の主な市場調査結果

第15章付録

List of Figures

TABLE OF CONTENTS

1 Study Coverage

2 Executive Summary

3 Competition by Manufacturers

4 Market Size by Type

5 Market Size by Application

6 North America

7 Europe

8 Asia Pacific

9 Latin America

10 Middle East and Africa

11 Company Profiles

12 Industry Chain and Sales Channels Analysis

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

14 Key Findings in The Global Restriction Endonucleases Study

15 Appendix

世界の制限酵素市場：考察と予測 (2028年まで)

Global Restriction Endonucleases Market Insights and Forecast to 2028

目次

第1章 調査対象

第2章 レポート概要

第3章 競合：メーカー別

第4章 市場規模：タイプ別

第5章 市場規模：アプリケーション別

第6章 北米

第7章 欧州

第8章 アジア太平洋

第9章 ラテンアメリカ

第10章 中東・アフリカ

第11章 企業プロファイル

第12章 業界チェーンと販売チャネルの分析

第13章 市場の促進要因, 機会, 課題とリスク要因の分析

第14章 世界の制限酵素の主な市場調査結果

第15章 付録

List of Figures

TABLE OF CONTENTS

1 Study Coverage

2 Executive Summary

3 Competition by Manufacturers

4 Market Size by Type

5 Market Size by Application

6 North America

7 Europe

8 Asia Pacific

9 Latin America

10 Middle East and Africa

11 Company Profiles

12 Industry Chain and Sales Channels Analysis

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

14 Key Findings in The Global Restriction Endonucleases Study

15 Appendix

第1章調査対象

第2章レポート概要

第3章競合：メーカー別

第4章市場規模：タイプ別

第5章市場規模：アプリケーション別

第6章北米

第7章欧州

第8章アジア太平洋

第9章ラテンアメリカ

第10章中東・アフリカ

第11章企業プロファイル

第12章業界チェーンと販売チャネルの分析

第13章市場の促進要因, 機会, 課題とリスク要因の分析

第14章世界の制限酵素の主な市場調査結果

第15章付録